We are live on ! Find out more
XLRN

Acceleron Pharma
XLRN

Delisted

XLRN was delisted on the 19th of November, 2021.

Back to rankings

84 hedge funds and large institutions have $639M invested in Acceleron Pharma in 2014 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 25 increasing their positions, 28 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

129% more call options, than puts

Call options by funds: $4.6M | Put options by funds: $2.01M

67% more funds holding in top 10

Funds holding in top 10: 3 → 5 (+2)

8% less funds holding

Funds holding: 91 → 84 (-7)

10% less capital invested

Capital invested by funds: $709M → $639M (-$69.9M)

11% less repeat investments, than reductions

Existing positions increased: 25 | Existing positions reduced: 28

37% less first-time investments, than exits

New positions opened: 12 | Existing positions closed: 19

Holders
84
Holders Change
-7
Holders Change %
-7.69%
% of All Funds
2.44%
Holding in Top 10
5
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+66.67%
% of All Funds
0.15%
New
12
Increased
25
Reduced
28
Closed
19
Calls
$4.6M
Puts
$2.01M
Net Calls
+$2.59M
Net Calls Change
-$474K

Top Buyers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
+$9.56M
2
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$6.39M
3
CAM
Cormorant Asset Management
Massachusetts
+$5.63M
4
PA
Perceptive Advisors
New York
+$4.08M
5
SAM
Sectoral Asset Management
Quebec, Canada
+$3.87M

Top Sellers

Rank Fund Capital Flow
1
Invesco
Invesco
Georgia
-$9.61M
2
State Street
State Street
Massachusetts
-$9.5M
3
O
OrbiMed
New York
-$5.84M
4
Franklin Resources
Franklin Resources
California
-$3.18M
5
IHM
Iguana Healthcare Management
New York
-$2.39M
Name Holding Trade Value Shares
Change 		Change in
Stake
State of New Jersey Common Pension Fund D
51
State of New Jersey Common Pension Fund D
New Jersey
$544K – – –
Swiss National Bank
52
Swiss National Bank
Switzerland
$457K – – –
GPCM
53
Granite Point Capital Management
Massachusetts
$454K – – –
State Board of Administration of Florida Retirement System
54
State Board of Administration of Florida Retirement System
Florida
$448K – – –
RhumbLine Advisers
55
RhumbLine Advisers
Massachusetts
$403K -$14.1K -500 -4%
MLICM
56
Metropolitan Life Insurance Company (MetLife)
New York
$393K – – –
NFA
57
Nationwide Fund Advisors
Ohio
$383K +$1.13K +40 +0.3%
AIG
58
American International Group
New York
$325K -$197 -7 -0.1%
CWG
59
C WorldWide Group
Denmark
$312K +$296K +10,500 New
TAM
60
Tocqueville Asset Management
New York
$305K -$77.5K -2,750 -21%
Brown Advisory
61
Brown Advisory
Maryland
$282K +$263K +9,324 New
VOYA Investment Management
62
VOYA Investment Management
Georgia
$271K -$1.7M -60,466 -87%
American Century Companies
63
American Century Companies
Missouri
$255K +$238K +8,431 New
Susquehanna International Group
64
Susquehanna International Group
Pennsylvania
$246K -$76.1K -2,703 -25%
SO
65
STRS Ohio
Ohio
$230K +$214K +7,600 New
HCM
66
Highbridge Capital Management
New York
$220K -$184K -6,516 -47%
NSEDCP
67
NJ State Employees Deferred Compensation Plan
New Jersey
$212K – – –
Citigroup
68
Citigroup
New York
$145K +$36.2K +1,285 +37%
Legal & General Group
69
Legal & General Group
United Kingdom
$97K +$92.1K +3,269 New
GT
70
Glenmede Trust
Pennsylvania
$81K – – –
EWM
71
Evercore Wealth Management
New York
$50K – – –
Wells Fargo
72
Wells Fargo
California
$39K -$14.5K -513 -28%
MOACM
73
Mutual of America Capital Management
New York
$38K +$10K +355 +39%
Bank of America
74
Bank of America
North Carolina
$36K -$2.79K -99 -8%
PAM
75
Panagora Asset Management
Massachusetts
$31K – – –
1 2
3
4 5

XLRN Hedge Fund Activity: Q3 2014 in Review

84 of the 3,446 institutional investors tracked by Wall St. Rank reported a position in Acceleron Pharma (XLRN) for Q3 2014, worth a combined $639M — down 9.9% from $709M a quarter earlier.

Sellers outnumbered buyers: 19 funds closed out of XLRN and 12 opened new positions — a net loss of 7 holders — while 28 trimmed existing stakes and 25 added.

The largest buyer was Citadel Advisors, adding an estimated $9.56M. The largest seller was Invesco, exiting entirely with an estimated $9.61M sold.

  • 84 institutional investors held Acceleron Pharma (XLRN) as of Q3 2014, down from 91 in Q2 2014.
  • Funds reported $639M of Acceleron Pharma stock for Q3 2014, down 9.9% quarter-over-quarter.
  • 12 funds opened new Acceleron Pharma positions in Q3 2014 and 19 closed out, a net change of -7 holders.
  • The largest Acceleron Pharma buyer in Q3 2014 was Citadel Advisors, an estimated $9.56M added.
  • The largest Acceleron Pharma seller in Q3 2014 was Invesco, an estimated $9.61M sold.

Based on aggregated 13F filings for Q3 2014.